echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Unanimous Konjac IPO: lower issue price after being asked

    Unanimous Konjac IPO: lower issue price after being asked

    • Last Update: 2022-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    News from this website (Reporter Wang Jinchen) Recently, Hubei Accord Konjac Biotechnology Co.


    It is worth noting that before the meeting, the Beijing Stock Exchange issued a key inquiry on issues such as the issue reserve price of Concord Konjac and the rationality of fundraising in the review inquiry letter


    In recent years, the operating performance of Accord Konjac has shown a continuous growth trend


    According to public information, Accord Konjac is mainly engaged in the deep processing of konjac and the research and development, production and sales of konjac-related products, including konjac flour, konjac food, and konjac cosmetics


    As early as November 2016, Accord Konjac was listed on the stock transfer system and publicly transferred, and its IPO application submitted to the Beijing Stock Exchange was also accepted on May 12, 2022, and the sponsor was Minmetals Securities


    Less than a month after the acceptance was accepted, the Beijing Stock Exchange disclosed an audit inquiry letter to Accord Konjac, in which the company was required to analyze and explain whether the existing issuance reserve price and price stabilization measures had an adverse impact on this public issuance


    After adjustment, the number of shares to be publicly issued by Accord Konjac decreased from 19.


    After this adjustment, the total amount of funds raised by Accord Konjac will be greatly reduced


    In terms of financial data, the operating performance of Accord Konjac has shown an increasing trend in recent years, but the gross profit margin has been declining year by year and is lower than the average level of comparable companies


    The prospectus shows: From 2019 to 2021, the revenue of Accord Konjac is about 366 million yuan, 379 million yuan and 501 million yuan respectively, an increase of about 22.


    During the reporting period, the company's sales revenue of konjac flour was approximately 321 million yuan, 331 million yuan and 430 million yuan respectively; accounting for 88.


    As of the disclosure date of the prospectus, Wu Ping and Li Li, the actual controllers of Accord Konjac, only controlled 66.


    Accord Konjac also disclosed the risk of improper control by the actual controller.


    The Beijing Stock Exchange requires Concord Konjac to explain whether its qualification acquisition and project approval comply with relevant laws and regulations, whether there is commercial bribery or other unfair competition, and whether the above-mentioned matters constitute major illegal acts, and requires it to fully disclose relevant risks


     

    Responsible editor: Zhao Yu Review: Peng Zonglu

     

     

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.